Back to results
US 8,283,376 B2Granted
Use of substituted 2-aminotetralins for preventive treatment of parkinson's disease
AssigneeUCB Pharma S.A.
InventorsDieter Scheller, Frank Dressen
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of substituted 2-aminotetralins of general formula (I) as a medicament for the preventive treatment of Parkinson's disease.
Claims12
A method for treatment of dopaminergic cell loss in a subject or decreasing the progression of Parkinson's disease in a subject, comprising
- (a) identifying a subject without clinically confirmed Parkinson's disease;
- and
- (b) administering to the subject rotigotine or a physiologically acceptable salt thereof.
A method for treatment of dopaminergic cell loss in a subject or decreasing the progression of Parkinson's disease in a subject, comprising
- (a) identifying a subject without any of four cardinal symptoms of Parkinson's disease but having an increased risk of developing Parkinson's disease;
- and
- (b) administering to the subject rotigotine or a physiologically acceptable salt thereof.
Dependencies are inferred from the claim text.